Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue Depreciation & Amortization (IS)EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Rent Expense Shares Outstanding Shares Outstanding Wages, Salaries and Other

Ardent Health (ARDT) Long-Term Debt Issuances (2023 - 2024)

Ardent Health has reported Long-Term Debt Issuances over the past 2 years, most recently at $1.8 million for Q3 2024.

Quarterly results put Long-Term Debt Issuances at $1.8 million for Q3 2024, changed N/A from a year ago — trailing twelve months through Jun 2025 was $1.8 million (down 74.94% YoY), and the annual figure for FY2024 was $3.6 million, down 45.61%.
Long-Term Debt Issuances for Q3 2024 was $1.8 million at Ardent Health, up from $847000.0 in the prior quarter.
Over the last five years, Long-Term Debt Issuances for ARDT hit a ceiling of $5.4 million in Q4 2023 and a floor of $847000.0 in Q2 2024.